Home » Authors » James Etheridge

Articles by James Etheridge

BioAlliance Starting Phase III Trial, Exploring Opportunities

May 24, 2006

By James Etheridge

NicOx, Grupo Ferrer Select Candidate For Development

May 17, 2006

By James Etheridge

Diatos Plans IPO, Licenses DaunoXome For Leukemia

May 17, 2006

By James Etheridge

Diatos Plans IPO, Licenses DaunoXome For Leukemia

May 17, 2006

By James Etheridge

NicOx, Grupo Ferrer Select Candidate For Development

May 17, 2006

By James Etheridge

BioAlliance Pharma Forms Subsidiary To Sell Loramyc

May 10, 2006

By James Etheridge

Planning Phase III, NicOx Brings In €43M Privately

May 10, 2006

By James Etheridge

Planning Phase III, NicOx Brings In €43M Privately

May 10, 2006

By James Etheridge

No Abstract

BioAlliance Pharma Forms Subsidiary To Sell Loramyc

May 10, 2006

By James Etheridge

MAT BioPharma Plans Phase III Trial, Negotiates EUR12M Funding

May 3, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...